Literature DB >> 18554353

A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone).

Christopher Welsh1, Susan G Sherman, Karin E Tobin.   

Abstract

BACKGROUND: Opioid overdose is a major source of morbidity and mortality in injection drug users in the United States and many other countries. CASE DESCRIPTION: A case is described in which buprenorphine/naloxone (Suboxone) was administered sublingually to reverse a heroin overdose.
CONCLUSIONS: Sublingually administered buprenorphine/naloxone might be used as a means to reverse opioid overdose.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554353     DOI: 10.1111/j.1360-0443.2008.02244.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  5 in total

1.  Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose.

Authors:  Michael A Yokell; Nickolas D Zaller; Traci C Green; Michelle McKenzie; Josiah D Rich
Journal:  J Opioid Manag       Date:  2012 Jan-Feb

2.  Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention.

Authors:  Karla D Wagner; Lin Liu; Peter J Davidson; Jazmine Cuevas-Mota; Richard F Armenta; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2015-05-27       Impact factor: 4.492

3.  The use of buprenorphine/naloxone to treat borderline personality disorder: a case report.

Authors:  Brenna Hansen; Katelyn M Inch; Brenna A Kaschor
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2022-03-15

Review 4.  Treatment of opioid overdose: current approaches and recent advances.

Authors:  Stevie C Britch; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2022-04-07       Impact factor: 4.530

5.  Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis.

Authors:  Rachel S Wightman; Jeanmarie Perrone; Rachel Scagos; Maxwell Krieger; Lewis S Nelson; Brandon D L Marshall
Journal:  J Med Toxicol       Date:  2020-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.